Shan Dong Kexing Bioproducts Co.,Ltd. Posted 9.9 Million Yuan Net Loss in First Quarter of 2023

Shan Dong Kexing Bioproducts Co.,Ltd. (科兴生物制药股份有限公司) (688136.SH) reported a net loss of 9.9 million yuan in the first quarter of 2023, reversing a net profit of 29.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 322.6 million yuan in revenue, up 19.6% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 42.3%.